To investigate the effects of DNA alterations associated with resistance against endocrine treatment on the expression of ER target genes, we here present the integration of RNA sequencing with WGS data obtained from metastatic lesions of a relatively large cohort of patients with ER-positive/HER2-negative breast cancer. Here, ESR1 is linked to breast cancer.